IL17A and COVID-19: IL-17A (p = 0.0010) and IL-23 (p = 0.0064) showed 96% and 241% higher values, respectively, in individuals with severe COVID-19 compared to those with critical COVID-19, whereas 146% higher values of IL-6 (p = 0.0083) was observed in individuals with moderate COVID-19 compared to those with critical COVID-19 (Figure 2).